CorMedix (CRMD) Deferred Taxes (2010 - 2025)

CorMedix (CRMD) posted Deferred Taxes of $33.9 million for Q4 2025, up 156.77% sequentially from -$59.7 million in Q3 2025.

CorMedix (CRMD) Deferred Taxes (2010 - 2025) Analysis & Trends

CorMedix has reported Deferred Taxes for 7 years, with the latest figure at $33.9 million in Q4 2025.

Quarterly Deferred Taxes changed N/A year-over-year to $33.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$25.8 million (changed N/A YoY) and the FY2025 annual result came in at -$25.8 million, changed N/A from the prior year.
Deferred Taxes improved to $33.9 million in Q4 2025 per CRMD's latest filing, from -$59.7 million in the prior quarter.
Over five years, Deferred Taxes peaked at $33.9 million in Q4 2025 and troughed at -$59.7 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-69.70 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	194.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	2.66 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	CorMedix	645.20 Mn	388.51 Mn	77.13 Mn	-

Download Data